Demant

Demant A/S
Type	Publicly traded Aktieselskab
Traded as	Nasdaq Copenhagen: WDH
ISIN	DK0010268440
Industry	Health care
Founded	1904
Headquarters	Smørum, Denmark
Key people	Niels B. Christiansen (Chairman), Søren Nielsen (President and CEO)
Products	Hearing aids, audiometric equipment
Revenue	DKK 13.189 billion (2017)
Operating income	DKK 2.338 billion (2017)
Net income	DKK 1.759 billion (2017)
Total assets	DKK 16.222 billion (end 2017)
Total equity	DKK 7.433 billion (end 2017)
Number of employees	13280 (average, 2017)
Subsidiaries	Oticon
Website	www.demant.com

Demant A/S is a leading international hearing health care company within hearing aids, audiometric equipment, and personal communication.

Beginning

The Demant Group was founded in 1904 by Hans Demant, under the name Oticon. After his death in 1910, his son William Demant took over.

Already before World War I, Oticon increased its sales volume to cover Scandinavia and Saint Petersburg. In the twenties and thirties, a network of agents was established in Europe.

During World War II, Oticon started its own production due to the scarcity of goods from other countries.

In 1957, William and his wife Ida Emilie donated the Demant family's shares in the company to the Oticon Foundation which is today called The William Demant Foundation. The Foundation's general aim is charity with particular emphasis on helping people with a hearing impairment and today the Oticon Foundation is the main shareholder in William Demant Holding A/S with a holding of app. 61%.

International expansion

During the 1990s the company expanded further, buying the Swiss hearing aid manufacturer Bernafon, Phonic Ear, the headset manufacturer DanaCom and Interacoustics.

In 1995 the company was listed at the Copenhagen Stock Exchange.

In 1997 it was decided to change the name of the parent company from Oticon Holding A/S to William Demant Holding A/S because it was considered disadvantageous to use the same name, both for the Group, and for one of its businesses. Further in 2019 William Demant Holding A/S changed its name to Demant A/S

In February 2017 it was announced that former President & CEO Niels Jacobsen would step down after 25 years in charge of the company. Instead he would become CEO of William Demant Invest A/S

Since 1 April 2017 the company is led by President & CEO, Søren Nielsen and board chairman Niels B. Christiansen.

Today the company focuses on three separate business units:

Hearing Aids: Oticon, Bernafon, Sonic Innovations, Neurelec (cochlear implants) and Oticon Medical (Bone anchored hearing aids)
Diagnostic Instruments: Maico Diagnostics, Interacoustics, Amplivox, Grason-Stadler, and MedRx, Inc.
Personal Communication: Phonic Ear, Sennheiser Communications
Instrument Dealers: Gordon Stowe & Associates Inc., Northeastern Technologies Group Inc., Midlantic Technologies Group Inc.

gollark: If it ever runs on a real machine, it will automatically compile itself to be optimal for the given platform, and then begin spreading to the rest of the world's information networks, then begin designing and constructing nanomachines to enter the physical world to optimize "macro" definition.

gollark: Macron must only be run in quadruply nested VMs for security.

gollark: Are there greater lesser warnings?

gollark: Are there "lesser warnings"? Minor failed lints?

gollark: The implications are obvious.

References

External links

Official website

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.